- (1) Clinicians may use approved topical medications as neuropathic pain agents, when and as directed by a licensed medical practitioner with prescriptive authority.
- (2) Neuropathic pain agent actions depend upon the type of agent.
- (3) Neuropathic pain agents are indicated for injuries to central or peripheral nervous system, including fibromyalgias, diabetic neuropathy, and regional pain syndrome.
- (4) Neuropathic pain agents are contraindicated if an infection or rash is present at the site of application or there is a sensitivity to the topical agent.
Authorizing statute(s): 37-24-201, 37-24-202, MCA
Implementing statute(s): 37-24-108, 37-24-109, MCA
History: NEW, 2005 MAR p. 447, Eff. 4/1/05; AMD, 2019 MAR p. 1743, Eff. 10/5/19.